Bionoid Pharma Company Executives
| BINP Stock | USD 0.27 0.02 8.00% |
Discussion of Bionoid Pharma's management performance can provide insight into the enterprise performance.
| Patricia Colvin Insider Director Controller |
Bionoid |
Bionoid Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (1.6412) % which means that it has lost $1.6412 on every $100 spent on assets. This is way below average. Bionoid Pharma's management efficiency ratios could be used to measure how well Bionoid Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Bionoid Pharma Workforce Comparison
Bionoid Pharma is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 66,863. Bionoid Pharma adds roughly 5.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Bionoid Pharma Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bionoid Pharma Price Series Summation is a cross summation of Bionoid Pharma price series and its benchmark/peer.
Bionoid Pharma Stakeholder
| Patricia Colvin | Director Controller | Profile |
About Bionoid Pharma Management Performance
The success or failure of an entity such as Bionoid Pharma often depends on how effective the management is. Bionoid Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bionoid management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bionoid management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bionoid Pharma Inc. engages in the hemp cultivation business. Bionoid Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people.
Bionoid Pharma Workforce Analysis
Traditionally, organizations such as Bionoid Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bionoid Pharma within its industry.Bionoid Pharma Manpower Efficiency
Return on Bionoid Pharma Manpower
| Revenue Per Employee | 18.5K | |
| Net Loss Per Employee | 324.6K |
Additional Tools for Bionoid Pink Sheet Analysis
When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.